California Life Sciences Association (CLSA) Applauds Gov.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
California Life Sciences Association (CLSA) Applauds Gov. Brown on Budget that Invests $10 Million in Precision Medicine Research

SOUTH SAN FRANCISCO & SAN DIEGO, Jan. 8, 2016 (GLOBE NEWSWIRE) -- The California Life Sciences Association (CLSA) today issued the following statement from CLSA President & CEO Sara Radcliffe applauding Gov. Jerry Brown's 2016 – 2017 budget proposal that includes $10 million for precision medicine research. CLSA is the leading voice to drive innovation for California's life sciences sector, serving over 750 life sciences organizations across California. "California Life Sciences Association (CLSA) applauds Governor Jerry Brown and his Administration for their unwavering support of life sciences innovation, as demonstrated again in this year's budget which calls for a $10 million investment in precision medicine research. California is the birthplace of biotechnology and today the state's life sciences sector employs over 281,000 people working to develop innovative new medicines, technologies and therapies needed to treat and cure patients. "We look forward to working with the Governor to best invest these research dollars to better understand and combat disease in the 21st century. Many CLSA member companies, universities and research institutes are already working in the precision medicine space and we applaud Governor Brown for his thoughtful and visionary support to advance this important research here in California." Click here to view the budget proposal. About California Life Sciences Association (CLSA)

California Life Sciences Association (CLSA) is the leading voice for California's life sciences sector. We work closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California's life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state's most influential life sciences advocacy and business leadership organization. Visit CLSA at www.califesciences.org , and follow us on Twitter @ CALifeSciences , Facebook , Instagram , LinkedIn and YouTube .  

Will Zasadny Manager, Communications for CLSA 619-961-8848

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ethereum's Path: Staking ETFs and Potential Momentum Gains

Updated Category News Views 97

Ethereum and Its Sideways Trading Ethereum (ETH/USD) is currently experiencing a period of sideways trading. Yet, amidst this stagnation, there is growing speculation regarding the upcoming Ethereum staking ETFs that could invigorate its price movement. Anticipated Breakout and Price Predictions Traders are showing optimism, expecting Ethereum to gradually climb. It’s...

Continue Reading
Editas Medicine Showcases Remarkable Gene Editing Advances in Liver Research

Updated Category News Views 146

Editas Medicine Showcases Gene Editing Breakthroughs In the realm of biotechnology, few areas hold as much promise as gene editing. Editas Medicine, a leader in this field, has taken significant strides towards harnessing the power of this technology for medical advancements. Their latest in vivo proof-of-concept data, which was unveiled at a prestigious annual meeting,...

Continue Reading
Alpha Modus Takes Legal Action Against Cooler Screens for Patent Breach

Updated Category News Views 124

Alpha Modus Initiates Patent Infringement Legal Action Alpha Modus Holdings Inc. (NASDAQ: AMOD), a pioneering company in AI-driven retail engagement technologies, has taken a significant step by filing a patent infringement lawsuit against Cooler Screens, Inc. The lawsuit has been lodged in the Northern District Court of Illinois, outlining serious allegations of...

Continue Reading
Banco Latinoamericano Stock Hits Record Highs Amid Growth

Updated Category News Views 220

Banco Latinoamericano Achieves New Heights In an exciting showcase of financial resilience, Banco Latinoamericano SA (NYSE: BLX) has achieved a remarkable milestone as stock prices soared to an impressive $37.44. This new 52-week high comes at a time of robust growth, with the bank enjoying a market capitalization of approximately $1.37 billion and a price-to-earnings...

Continue Reading
Key Insights on Nucor Corp's Earnings Outlook Ahead

Updated Category News Views 186

Nucor Corp's Upcoming Earnings Report Nucor (NYSE: NUE) is gearing up to unveil its quarterly earnings report soon. Investors are particularly eager to learn how the company has performed over the last few months leading up to this highly anticipated announcement. What Analysts Are Expecting Financial analysts are forecasting Nucor to post an earnings per share (EPS) of...

Continue Reading